Arun B. Jesudian, MD, and Kimberly A. Brown, MD, provide an overview of hepatic encephalopathy, signs and symptoms, and underlying liver disease as a major risk factor.

Kimberly A. Brown, MD, reviews classifying the severity of HE and defines covert vs overt HE.

Experts in hepatology discuss the pathophysiology of HE and how certain factors influence the brain in HE.

Kimberly A. Brown, MD, comments on the life-threatening nature of recurrent HE and how to navigate patient conversations.

Expert hepatologists discuss how to identify patients with hepatic encephalopathy who require hospitalization vs outpatient care.

Experts in hepatology comment on effectiveness of diagnostic testing hepatic encephalopathy.

Arun B. Jesudian, MD, and Kimberly A. Brown, MD, discuss conditions that may be mistaken for hepatic encephalopathy.

Kimberly A. Brown, MD, reviews the use of lactulose and rifaximin as first-line treatment of hepatic encephalopathy.

Arun B. Jesudian, MD, and Kimberly A. Brown, MD, highlight clinical trial data of rifaximin for the treatment of hepatic encephalopathy.

Expert hepatologists comment on primary care providers using rifaximin to manage and prevent episodes of hepatic encephalopathy.

Kimberly A. Brown, MD, shares approaches to educating patients on management of hepatic encephalopathy and the importance of medication adherence and nutrition.

Hepatology experts discuss educating patients with hepatic encephalopathy on managing medications and supplements.